文献速递心胸血管麻醉

体外循环期间氧输送与术后死亡率:回顾性队列研究

Oxygen delivery during cardiopulmonary bypass and postoperative mortality: A retrospective cohort study.
PubMed 文献 · Anesthesiology · 2026-09-28

该回顾性队列纳入4358例体外循环心脏手术成人患者,计算时间加权平均指数化氧输送(DO2i)。DO2i每降低10 ml·min⁻¹·m⁻²,30天死亡风险增加(ORadj 1.16),且与急性肾损伤和住院时间延长相关,但与卒中无关。

要点

  • 体外循环期间DO2i降低与30天死亡率升高独立相关。
  • DO2i降低亦与术后急性肾损伤及ICU和住院时间延长相关。
  • DO2i与术后卒中无显著关联。

核心结论

  • 体外循环期间较低的术中DO2i与术后死亡率、急性肾损伤及恢复时间延长风险升高相关。

研究设计与样本

  • 回顾性队列研究,纳入2018至2024年单中心4358例体外循环心脏手术成人患者。

主要发现

  • 75例(1.7%)在30天内死亡。
  • DO2i每降低10 ml·min⁻¹·m⁻²,死亡风险增加(ORadj 1.16;95%CI 1.09-1.23;P<0.001)。
  • DO2i第25百分位(226.2 ml·min⁻¹·m⁻²)时调整30天死亡率为1.69%(95%CI 1.32-2.05%),第75百分位(295.6 ml·min⁻¹·m⁻²)时为0.74%(95%CI 0.41-1.07%)。
  • 较低DO2i与急性肾损伤(ORadj 1.05;95%CI 1.03-1.07;P<0.001)、ICU停留时间(IRRadj 1.02;95%CI 1.01-1.03;P<0.001)和住院时间(IRRadj 1.01;95%CI 1.01-1.02;P<0.001)延长相关。
  • DO2i与卒中无显著关联(ORadj 1.00;95%CI 0.95-1.06;P=0.877)。

临床怎么用

  • 体外循环期间应关注并优化氧输送指标,可能有助于降低术后死亡和急性肾损伤风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Oxygen delivery during cardiopulmonary bypass reflects the balance between pump flow, hemoglobin concentration, and arterial oxygenation and is a key determinant of tissue oxygen transport. While inadequate oxygen delivery has been linked to postoperative organ dysfunction, its association with mortality remains unclear. METHODS: We conducted a retrospective cohort study including 4,358 adult patients undergoing cardiac surgery with cardiopulmonary bypass at a tertiary center between 2018 and 2024. Time-weighted average indexed oxygen delivery (DO2i) was calculated from pump flow, arterial oxygen saturation, hemoglobin concentration, and body surface area. The primary outcome was 30-day mortality. Secondary outcomes included postoperative acute kidney injury (AKI), stroke, and intensive care unit (ICU) and hospital length of stay. Associations were evaluated using multivariable regression models adjusted for demographic, clinical, and procedural factors. RESULTS: Lower intraoperative DO2i was associated with higher 30-day mortality. Overall, 75 patients (1.7%) died within 30 days. Each 10 ml · min -1 · m -2 decrease in DO2i was associated with increased odds of mortality (adjusted odds ratio [ORadj] 1.16; 95% CI 1.09-1.23; P < 0.001). The adjusted 30-day mortality was 1.69% (95% CI 1.32-2.05%) at the 25th percentile of DO2i (226.2 ml · min⁻¹ · m⁻²), compared with 0.74% (95% CI 0.41-1.07%) at the 75th percentile (295.6 ml · min⁻¹ · m⁻²). Lower DO2i was also associated with AKI (ORadj 1.05; 95% CI 1.03-1.07; P < 0.001), longer ICU (adjusted incidence rate ratio [IRRadj] 1.02; 95% CI 1.01-1.03; P < 0.001) and hospital length of stay (IRRadj 1.01; 95% CI 1.01-1.02; P < 0.001), but not with stroke (ORadj 1.00; 95% CI 0.95-1.06; P = 0.877). CONCLUSIONS: Patients receiving lower intraoperative DO2i during cardiopulmonary bypass had a higher risk of postoperative mortality, AKI, and prolonged recovery. These findings support the clinical relevance of oxygen delivery during bypass and provide a rationale for future mechanistic and interventional studies.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Robitaille MJ, Sahli SD, Wachtendorf LJ, et al. Oxygen delivery during cardiopulmonary bypass and postoperative mortality: A retrospective cohort study. Anesthesiology. 2026. PMID: 42803386. doi:10.1097/ALN.0000000000006393

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。